Trial Profile
A phase 2 study of trastuzumab and TS-1 for HER2-positive advanced gastric cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 05 Aug 2011 New trial record